Literature DB >> 30477691

Contribution of microRNAs to the immunosuppressive function of mesenchymal stem cells.

Yves-Marie Pers1, Marie Maumus2, Claire Bony2, Christian Jorgensen1, Danièle Noël3.   

Abstract

Mesenchymal stem/stromal cells (MSCs) are progenitor cells identified in many adult tissues, in particular in bone marrow or adipose tissue and, in placental tissues. MSCs exert pleiotropic functions that render them attractive for many clinical applications, both in degenerative and inflammatory diseases. Their main mode of action is through the secretion of trophic factors that can be released in the extracellular milieu or packaged within extracellular vesicles. These factors can be proteins, lipids, mRNAs or miRNAs that possess diverse effects, notably pro-angiogenic, anti-fibrotic, anti-apoptotic or anti-inflammatory. The anti-inflammatory role of a number of miRNAs has been demonstrated with different types of immune cells but few have been associated with the immunomodulatory function of MSCs. In this review, we summarize the data on the miRNAs that have been validated as participating to the anti-inflammatory role of MSCs.
Copyright © 2018 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30477691     DOI: 10.1016/j.biochi.2018.07.001

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

Review 1.  Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus.

Authors:  Wen-Yan Tang; Jia-Hua Liu; Chun-Jin Peng; Yao Liao; Jie-Si Luo; Xi Sun; Yan-Lai Tang; Xue-Qun Luo
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-03-13       Impact factor: 4.291

2.  Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I Study.

Authors:  Ellen Iacobaeus; Nadir Kadri; Katia Lefsihane; Erik Boberg; Caroline Gavin; Anton Törnqvist Andrén; Anders Lilja; Lou Brundin; Katarina Le Blanc
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

3.  miR-155 Contributes to the Immunoregulatory Function of Human Mesenchymal Stem Cells.

Authors:  Yves-Marie Pers; Claire Bony; Isabelle Duroux-Richard; Laurène Bernard; Marie Maumus; Said Assou; Frank Barry; Christian Jorgensen; Danièle Noël
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 7.561

4.  Editorial: The Role of Metabolism in MSC-Mediated Immunomodulation.

Authors:  Yves-Marie Pers; Christian Jorgensen; Maroun Khoury
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 7.561

Review 5.  Therapeutic effects of mesenchymal stem cells-derived extracellular vesicles' miRNAs on retinal regeneration: a review.

Authors:  Ali Rajool Dezfuly; Azadeh Safaee; Hossein Salehi
Journal:  Stem Cell Res Ther       Date:  2021-10-07       Impact factor: 6.832

6.  Effects of Adipose-Derived Biogenic Nanoparticle-Associated microRNA-451a on Toll-like Receptor 4-Induced Cytokines.

Authors:  Xinghua Wang; Anthony Pham; Lu Kang; Sierra A Walker; Irina Davidovich; Dalila Iannotta; Sarvam P TerKonda; Shane Shapiro; Yeshayahu Talmon; Si Pham; Joy Wolfram
Journal:  Pharmaceutics       Date:  2021-12-22       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.